Shares of other companies:
April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
Amazon Web Services Expands Bedrock GenAI Service
April 23, 2024
Why Microsoft Stands Out As A Pre-Earnings Buy
April 23, 2024
Wall Street Lunch: Big Tech Bearishness?
April 22, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
DERM Stock News and Mentions of Journey Medical Corp. Stocktwits
Updated: April 25, 2024 (01:57)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Journey Medical Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Journey Medical Corp. (DERM).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Journey Medical stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Journey Medical Corp. (DERM)
March 28, 2024 (20:05) / "GlobeNewswire" (by Inc.)
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Record consolidated net revenue of $84.5 million for ...
In Article Trend: Somewhat-Bullish
March 28, 2024 (11:14) / "Benzinga" (by Avi Kapoor)
Journey Medical And 2 Other Stocks Under $4 Insiders Are Buying - Journey Medical ( NASDAQ:DERM ) , Citizens ( NYSE:CIA )
The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...
In Article Trend: Somewhat-Bullish
March 19, 2024 (12:49) / "Zacks Commentary" (by Zacks Equity Research)
Journey Medical ( DERM ) Up as FDA Accepts Skin Disease Drug NDA
Journey Medical (DERM) stock rises as the FDA accepts its regulatory filing for review seeking approval for DFD-29 to treat inflammatory lesions and erythema of rosacea in adults.
In Article Trend: Neutral
March 18, 2024 (12:30) / "GlobeNewswire" (by Journey Medical Corporation)
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
Prescription Drug User Fee Act ( "PDUFA" ) goal date of November 4, 2024 Prescription Drug User Fee Act ( "PDUFA" ) goal date of November ...
In Article Trend: Neutral
March 15, 2024 (12:30) / "GlobeNewswire" (by Journey Medical Corporation)
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
Company to host conference call to discuss financial results and provide a corporate update on March 21, 2024 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide a corporate update on March 21, 2024 at 4:30 p.m. ET ...
In Article Trend: Somewhat-Bullish
March 13, 2024 (12:30) / "GlobeNewswire" (by Journey Medical Corporation)
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
SCOTTSDALE, Ariz., March 13, 2024 ( GLOBE NEWSWIRE ) -- Journey Medical Corporation ( "Journey Medical" ) ( Nasdaq: DERM ) , a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of ...
In Article Trend: Somewhat-Bullish
March 11, 2024 (12:30) / "GlobeNewswire" (by Journey Medical Corporation)
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 ( Minocycline Hydrochloride Modified Release Capsules, 40 mg ) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues ...
In Article Trend: Neutral
February 26, 2024 (16:35) / "Zacks Commentary" (by Zacks Equity Research)
Journey Medical ( DERM ) to Report Q4 Earnings: What's in the Cards?
When Journey Medical (DERM) reports fourth-quarter 2023 results, investors will likely focus on the top and bottom-line numbers.
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website